Develops drugs for rare diseases.
Dec 2025Revenue $804M/yrExpenses $774M/yr
No trend
Figures by year
Is Telix Pharmaceuticals profitable?
Yes. In the 12 months to Dec 2025, revenue was $804M and expenses $774M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $804M | $774M | $29.8M |
| Dec 2024 | $517M | $461M | $55.2M |
| Dec 2023 | $333M | $322M | $11.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.